Alice Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alice Ma has a total of 513 co-authors. Here are the top co-authors by number of shared publications:
- Amanda R. Decker-Farrell
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA
65 shared publications - Hans Carlo Maurer
Department of Internal Medicine II, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, 81675 Munich, Germany
65 shared publications - Kenneth P. Olive
Division of Digestive and Liver Diseases, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, USA
65 shared publications - Alexander Muir
Ben May Department for Cancer Research, University of Chicago
64 shared publications - Alvaro Curiel-Garcia
Division of Digestive and Liver Diseases, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, USA
64 shared publications - Andrea Califano
Department of Systems Biology, Columbia University, New York, USA
64 shared publications
Latest Publications
- Open Access
- 8 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
IPI-926 treatment alters cellular composition in the tumor microenvironment.
- 8 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
IPI-926 treatment alters cellular composition in the tumor microenvironment.
- Open Access
- 8 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 9 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
Myeloid network.Regulatory network for PDAC-associated myeloid cells, listing the inferred transcriptional targets (Target) for each regulatory protein (Regulator). Association weight (AW) and association mode (AM) are scores to quantify strength/direction of interaction. Sign indicates directionality of the interaction (1 = transactivating, -1 = transrepressing).
- 8 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 9 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
Myeloid network.Regulatory network for PDAC-associated myeloid cells, listing the inferred transcriptional targets (Target) for each regulatory protein (Regulator). Association weight (AW) and association mode (AM) are scores to quantify strength/direction of interaction. Sign indicates directionality of the interaction (1 = transactivating, -1 = transrepressing).
- Open Access
- 8 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
Abrogation of SHH signaling fuels hypersprouting in human and murine PDAC explants.
- 8 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 6 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
Abrogation of SHH signaling fuels hypersprouting in human and murine PDAC explants.
- Open Access
- 8 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
Overview of single cell regulatory network analysis.
- 8 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
Overview of single cell regulatory network analysis.
- Open Access
- 8 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
Explant cellular populations throughout culture.
- 8 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
Explant cellular populations throughout culture.
- Open Access
- 8 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 10 - 13 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
Supplementary Table 10: Antibodies for IHC and IF.Overview of antibodies used for stainings in human PDAC or KPC-derived tissues.Supplementary Table 11: Primer sequences for qRT-PCR.Primers for qRT-PCR-based quantification of ChIP and mRNA samples.Supplementary Table 12: Freezer dryer settings for sponge production.Specific settings for optimal sponge production.Supplementary Table 13: Explant media composition.List of reagents used for human PDAC and murine explants.
- 8 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 10 - 13 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
Supplementary Table 10: Antibodies for IHC and IF.Overview of antibodies used for stainings in human PDAC or KPC-derived tissues.Supplementary Table 11: Primer sequences for qRT-PCR.Primers for qRT-PCR-based quantification of ChIP and mRNA samples.Supplementary Table 12: Freezer dryer settings for sponge production.Specific settings for optimal sponge production.Supplementary Table 13: Explant media composition.List of reagents used for human PDAC and murine explants.
- Open Access
- 8 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
Explant cellular populations throughout culture.
- 8 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
Explant cellular populations throughout culture.
- Open Access
- 8 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Tables 1 - 4 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
Supplementary Table 1: Raw read counts per gene for bulk RNA-seq IPI-926 intervention study.Raw read counts of matching biopsy (Bx) and necropsy (Nx) bulk RNA-seq samples after two days of treatment with vehicle or IPI-926.Supplementary Table 2: Digestion buffer for single cell preparation.List of reagents optimized for single cell digestion of KPC-derived tumors.Supplementary Table 3: Single Cell RNA-seq Quality Control.Overview of KPC-derived scRNA-seq samples, containing treatment information (vehicle or IPI-926; n=3 each), sequencing depth, detected genes, and detection of mitochondrial genes (MT%).Supplementary Table 4: Network sizes in murine scRNA-seq data.Number of regulatory proteins for which regulons were generated in each network type, in each cell type, from KPC mouse pancreatic tumors.
- 8 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables 1 - 4 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
Supplementary Table 1: Raw read counts per gene for bulk RNA-seq IPI-926 intervention study.Raw read counts of matching biopsy (Bx) and necropsy (Nx) bulk RNA-seq samples after two days of treatment with vehicle or IPI-926.Supplementary Table 2: Digestion buffer for single cell preparation.List of reagents optimized for single cell digestion of KPC-derived tumors.Supplementary Table 3: Single Cell RNA-seq Quality Control.Overview of KPC-derived scRNA-seq samples, containing treatment information (vehicle or IPI-926; n=3 each), sequencing depth, detected genes, and detection of mitochondrial genes (MT%).Supplementary Table 4: Network sizes in murine scRNA-seq data.Number of regulatory proteins for which regulons were generated in each network type, in each cell type, from KPC mouse pancreatic tumors.
- Open Access
- 8 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
SHH secretion in vitro and ex vivo.
- 8 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
SHH secretion in vitro and ex vivo.